These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32645904)

  • 21. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell biology of the neurovascular unit: implications for drug delivery across the blood-brain barrier.
    McCarty JH
    Assay Drug Dev Technol; 2005 Feb; 3(1):89-95. PubMed ID: 15798399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
    Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
    FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury.
    Bhowmick S; D'Mello V; Caruso D; Wallerstein A; Abdul-Muneer PM
    Exp Neurol; 2019 Jul; 317():260-270. PubMed ID: 30926390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model.
    Xu L; Dan M; Shao A; Cheng X; Zhang C; Yokel RA; Takemura T; Hanagata N; Niwa M; Watanabe D
    Int J Nanomedicine; 2015; 10():6105-18. PubMed ID: 26491287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons.
    Canfield SG; Stebbins MJ; Faubion MG; Gastfriend BD; Palecek SP; Shusta EV
    Fluids Barriers CNS; 2019 Aug; 16(1):25. PubMed ID: 31387594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.
    Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T
    J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
    Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY
    Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of lipid nanocapsules loaded with iron oxide nanoparticles for magnetic targeting to the blood-brain barrier.
    Aparicio-Blanco J; Pucci C; De Pasquale D; Marino A; Debellis D; Ciofani G
    Drug Deliv Transl Res; 2024 May; ():. PubMed ID: 38739319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery.
    Liang J; Gao C; Zhu Y; Ling C; Wang Q; Huang Y; Qin J; Wang J; Lu W; Wang J
    ACS Appl Mater Interfaces; 2018 Sep; 10(36):30201-30213. PubMed ID: 30113810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
    Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
    Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
    Johnsen KB; Moos T
    J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier.
    Adriani G; Ma D; Pavesi A; Kamm RD; Goh EL
    Lab Chip; 2017 Jan; 17(3):448-459. PubMed ID: 28001148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-brain barrier transport machineries and targeted therapy of brain diseases.
    Barar J; Rafi MA; Pourseif MM; Omidi Y
    Bioimpacts; 2016; 6(4):225-248. PubMed ID: 28265539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.